2004N-0133 - Part 11 Public Meeting; June 11, 2004
FDA Comment Number : EC22
Submitter : Dr. Madeleine Kennedy Date & Time: 09/07/2004 08:09:24
Organization : Eli Lilly and Company
Drug Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
Eli Lilly and Company appreciates the opportunity to provide comments on Docket No. 2004N-0133. Attached are our comments.

Sincerely,

Madeleine Kennedy, Ph.D.
Director Computer Systems Quality Assurance

and

Michael Rutherford
Global Quality System Manager - Computer Systems